Shared on12 Oct 25Fair value Decreased 1.54%
Analysts have lowered their price target for Eastman Chemical from $86 to $75, citing expectations of softer revenue growth and a moderately higher discount rate. Analyst Commentary Bullish Takeaways Bullish analysts continue to maintain a Buy rating on Eastman Chemical, citing confidence in the company's longer-term fundamentals.
Shared on04 Aug 25Fair value Decreased 19%
Eastman Chemical's consensus price target was revised down as analysts tempered their revenue growth outlook and reduced the expected valuation multiple, resulting in a new fair value estimate of $83.29. What's in the News Repurchased 643,791 shares for $50 million, completing the buyback of 32,171,320 shares (24.84%) for $3.1 billion under its 2018 repurchase program.
Shared on30 Apr 25Fair value Decreased 8.57%
AnalystConsensusTarget has decreased revenue growth from 3.0% to 2.3%.
Shared on23 Apr 25Fair value Decreased 0.76%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25Fair value Decreased 3.93%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 1.43%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 0.47%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 0.94%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 18%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.